| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systems Biology and Emerging Technologies |
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California
Requests for reprints: Daojing Wang, Life Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, MS 977-250, Berkeley, CA 94720. Phone: 510-486-6592; Fax: 510-495-2535; E-mail: djwang{at}lbl.gov.
Key Words: mesenchymal stem cells ionizing radiation senescence cytoskeletal reorganization CK2
Human mesenchymal stem cells (hMSC) are critical for tissue regeneration. How hMSC respond to genotoxic stresses and potentially contribute to aging and cancer remain underexplored. We showed that ionizing radiation induced cellular senescence of hMSC over a period of 10 days, showing a critical transition between days 3 and 6. This was confirmed by senescence-associated β-galactosidase staining, protein expression profiles of key cell cycle regulators (retinoblastoma protein, p53, p21waf1/Cip1, and p16INK4A), and senescence-associated secretory phenotypes (interleukin-8, interleukin-12, GRO, and MDC). We observed dramatic cytoskeletal reorganization of hMSC through reduction of myosin-10, redistribution of myosin-9, and secretion of profilin-1. Using a SILAC-based phosphoproteomics method, we detected significant reduction of myosin-9 phosphorylation at Ser1943, coinciding with its redistribution. Importantly, through treatment with cell-permeable inhibitors (4,5,6,7-tetrabromo-1H-benzotriazole and 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole) and gene knockdown using RNA interference, we identified CK2, a kinase responsible for myosin-9 phosphorylation at Ser1943, as a key factor contributing to the radiation-induced senescence of hMSC. We showed that individual knockdown of CK2 catalytic subunits CK2
and CK2
' induced hMSC senescence. However, only knockdown of CK2
resulted in morphologic phenotypes resembling those of radiation-induced senescence. These results suggest that CK2
and CK2
' play differential roles in hMSC senescence progression, and their relative expression might represent a novel regulatory mechanism for CK2 activity. [Cancer Res 2009;69(20):8200–7]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |